ACCELERON PHARMA INC - COMMON STOCK (XLRN)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
21,141,565
Share change
+262,206
Total reported value
$639,314,054
Put/Call ratio
95%
Price per share
$30.24
Number of holders
83
Value change
+$5,549,665
Number of buys
36
Number of sells
47

Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q3 2014

As of 30 Sep 2014, ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by 83 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,141,565 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Polaris Venture Management Co IV LLC, ADAGE CAPITAL PARTNERS GP LLC, QVT Financial LP, VANGUARD GROUP INC, Sectoral Asset Management Inc, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, and PERCEPTIVE ADVISORS LLC. This page lists 83 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.